Mirum Pharmaceuticals Inc (MIRM)
25.72
+0.61
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Market Cap: 1.209B for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.209B |
| April 30, 2024 | 1.180B |
| April 29, 2024 | 1.178B |
| April 26, 2024 | 1.150B |
| April 25, 2024 | 1.151B |
| April 24, 2024 | 1.129B |
| April 23, 2024 | 1.148B |
| April 22, 2024 | 1.136B |
| April 19, 2024 | 1.119B |
| April 18, 2024 | 1.108B |
| April 17, 2024 | 1.121B |
| April 16, 2024 | 1.129B |
| April 15, 2024 | 1.124B |
| April 12, 2024 | 1.155B |
| April 11, 2024 | 1.214B |
| April 10, 2024 | 1.205B |
| April 09, 2024 | 1.231B |
| April 08, 2024 | 1.218B |
| April 05, 2024 | 1.234B |
| April 04, 2024 | 1.191B |
| April 03, 2024 | 1.163B |
| April 02, 2024 | 1.185B |
| April 01, 2024 | 1.196B |
| March 28, 2024 | 1.181B |
| March 27, 2024 | 1.181B |
| Date | Value |
|---|---|
| March 26, 2024 | 1.171B |
| March 25, 2024 | 1.229B |
| March 22, 2024 | 1.228B |
| March 21, 2024 | 1.224B |
| March 20, 2024 | 1.269B |
| March 19, 2024 | 1.270B |
| March 18, 2024 | 1.221B |
| March 15, 2024 | 1.258B |
| March 14, 2024 | 1.324B |
| March 13, 2024 | 1.305B |
| March 12, 2024 | 1.292B |
| March 11, 2024 | 1.266B |
| March 08, 2024 | 1.323B |
| March 07, 2024 | 1.318B |
| March 06, 2024 | 1.327B |
| March 05, 2024 | 1.308B |
| March 04, 2024 | 1.340B |
| March 01, 2024 | 1.368B |
| February 29, 2024 | 1.341B |
| February 28, 2024 | 1.350B |
| February 27, 2024 | 1.383B |
| February 26, 2024 | 1.358B |
| February 23, 2024 | 1.299B |
| February 22, 2024 | 1.319B |
| February 21, 2024 | 1.322B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
157.25M
Minimum
Nov 20 2019
1.628B
Maximum
Dec 15 2023
702.64M
Average
602.64M
Median
Market Cap Benchmarks
| Gilead Sciences Inc | 81.69B |
| Vanda Pharmaceuticals Inc | 274.45M |
| Sarepta Therapeutics Inc | 12.27B |
| Puma Biotechnology Inc | 237.90M |
| Reneo Pharmaceuticals Inc | 57.48M |
Market Cap Related Metrics
| PS Ratio | 5.641 |
| PEG Ratio | -69.60 |
| Price to Book Value | 4.862 |
| Price | 25.72 |
| Earnings Yield | -15.63% |
| PEGY Ratio | -69.60 |